Literature DB >> 1639058

Stable surface expression of invariant chain prevents peptide presentation by HLA-DR.

P A Roche1, C L Teletski, D R Karp, V Pinet, O Bakke, E O Long.   

Abstract

Class II major histocompatibility complex (MHC) molecules are cell surface glycoproteins that bind and present immunogenic peptides to T cells. Intracellularly, class II molecules associate with a polypeptide referred to as the invariant (Ii) chain. Ii is proteolytically degraded and dissociates from the class II complex prior to cell surface expression of the mature class II alpha beta heterodimer. Using human fibroblasts transfected with HLA-DR1 and Ii cDNAs, we now demonstrate that truncation of the cytoplasmic domain of Ii results in the failure of Ii to dissociate from the alpha beta Ii complex and leads to stable expression of class II alpha beta Ii complexes on the cell surface. Furthermore, biochemical analysis and peptide presentation assays demonstrated that transfectants with stable surface alpha beta Ii complexes expressed very few free alpha beta heterodimers at the surface and were very inefficient in their ability to present immunogenic peptides to T cells. These results support the hypothesis that the cytoplasmic domain of Ii is responsible for endosomal targeting of alpha beta Ii and directly demonstrate that association with Ii interferes with the antigen presentation function of class II molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639058      PMCID: PMC556763          DOI: 10.1002/j.1460-2075.1992.tb05351.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

Review 1.  Antigen processing for presentation to CD4+ T cells.

Authors:  E O Long
Journal:  New Biol       Date:  1992-04

2.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.

Authors:  L Teyton; D O'Sullivan; P W Dickson; V Lotteau; A Sette; P Fink; P A Peterson
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

3.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains.

Authors:  V E Reyes; S Lu; R E Humphreys
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

5.  Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74).

Authors:  N Koch; G Moldenhauer; W J Hofmann; P Möller
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

6.  Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.

Authors:  C E Machamer; P Cresswell
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus.

Authors:  C A Lamb; J W Yewdell; J R Bennink; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

8.  Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells.

Authors:  E O Long; S Rosen-Bronson; D R Karp; M Malnati; R P Sekaly; D Jaraquemada
Journal:  Hum Immunol       Date:  1991-08       Impact factor: 2.850

9.  The membrane spanning domain of beta-1,4-galactosyltransferase specifies trans Golgi localization.

Authors:  T Nilsson; J M Lucocq; D Mackay; G Warren
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.

Authors:  D R Karp; E O Long
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  29 in total

1.  HIV-1 Nef impairs MHC class II antigen presentation and surface expression.

Authors:  P Stumptner-Cuvelette; S Morchoisne; M Dugast; S Le Gall; G Raposo; O Schwartz; P Benaroch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

2.  Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.

Authors:  D R Karp; R N Jenkins; E O Long
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

Authors:  Azizul Haque; Laela M Hajiaghamohseni; Ping Li; Katherine Toomy; Janice S Blum
Journal:  Cell Immunol       Date:  2007-12-11       Impact factor: 4.868

4.  Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway.

Authors:  Even Walseng; Oddmund Bakke; Paul A Roche
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

Review 5.  Protein sorting within the MHC class II antigen-processing pathway.

Authors:  M S Marks
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.

Authors:  Andrey Tokarev; John Guatelli
Journal:  Cell Logist       Date:  2011-05

Review 7.  Endosomal localization of MHC class II-invariant chain complexes.

Authors:  J Miller
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

8.  Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

Authors:  Michael Schindler; Stephanie Würfl; Philippe Benaroch; Thomas C Greenough; Rod Daniels; Philippa Easterbrook; Matthias Brenner; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors.

Authors:  Frank Kirchhoff; Michael Schindler; Nicola Bailer; G Herma Renkema; Kalle Saksela; Volker Knoop; Michaela C Müller-Trutwin; Mario L Santiago; Frederic Bibollet-Ruche; Matthias T Dittmar; Jonathan L Heeney; Beatrice H Hahn; Jan Münch
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 10.  Association of intracellular proteins with folded major histocompatibility complex class I molecules.

Authors:  Chantey R Morris; Adrian J Reber; Jason L Petersen; Shanna E Vargas; Joyce C Solheim
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.